v3.24.1.1.u2
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Cash flows from operating activities:    
Net loss $ (125,714) $ (146,774)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 8,066 2,987
Amortization of operating lease right-of-use assets 2,010 1,610
Amortization of premium (discount) on marketable securities (870) (743)
Loss on marketable securities 2,320 3,033
Change in fair value of private warrants (821) 1,054
Vendor stock-in-lieu of cash program 4,034 5,684
Gain from acquisition of EM4 (1,752) 0
Amortization of debt discount and issuance costs 809 809
Inventory write-offs and write-downs 16,903 5,451
Share-based compensation 44,465 55,954
Product warranty and other (1,684) 586
Changes in operating assets and liabilities:    
Accounts receivable (13,846) (9,877)
Inventories (17,586) (11,578)
Prepaid expenses and other current assets (7,495) 9,932
Other non-current assets (1,071) (4,156)
Accounts payable 6,128 11,191
Accrued and other current liabilities 7,445 11,651
Other non-current liabilities (2,570) (1,488)
Net cash used in operating activities (81,229) (64,674)
Cash flows from investing activities:    
Purchases of marketable securities (48,827) (81,623)
Proceeds from maturities of marketable securities 88,990 148,345
Proceeds from sales/redemptions of marketable securities 274 20,165
Purchases of property and equipment (1,284) (11,680)
Net cash provided by investing activities 34,426 62,599
Cash flows from financing activities:    
Net proceeds from issuance of Class A common stock under the Equity Financing Program 17,230 22,665
Proceeds from exercise of stock options 371 1,036
Payments of employee taxes related to stock-based awards (126) (572)
Net cash provided by financing activities 17,475 23,129
Net increase (decrease) in cash, cash equivalents and restricted cash (29,328) 21,054
Beginning cash, cash equivalents and restricted cash 140,624 71,105
Ending cash, cash equivalents and restricted cash 111,296 92,159
Supplemental disclosures of noncash investing and financing activities:    
Operating lease right-of-use assets obtained in exchange for lease obligations 3,842 1,211
Purchases of property and equipment recorded in accounts payable and accrued liabilities 299 7,978
Vendor stock-in-lieu of cash program—advances for capital projects and equipment 0 2,520
EM4    
Adjustments to reconcile net loss to net cash used in operating activities:    
Gain from acquisition of EM4 (1,800)  
Cash flows from investing activities:    
Acquisition of EM4 (net of cash acquired) (4,727) 0
Seagate    
Cash flows from investing activities:    
Acquisition of Seagate’s lidar business $ 0 $ (12,608)

Source

PDF HTML